New Medication Option for adults with ADHD in Canada

A new treatment option for adult ADHD patients was approved by Health Canada in December 2017 and is now available in pharmacies. Foquest® (methylphenidate HCl controlled-release capsules), from Purdue Pharma Canada, is indicated for the treatment of ADHD in adults (≥18 years of age).
Foquest is a once-daily, long-acting methylphenidate controlled-release capsule that has an onset of action within one hour and a 16-hour duration of action. It is available in seven capsule strengths – 25, 35, 45, 55, 70, 85, 100 mg.

The website is hand-crafted in ZippyHippo online marketing studio.